BioNano Consulting (BNC) predicts impending patent loss will accelerate adoption of nanotechnology in drug formulation and head to US to boost US business.
Novo Nordisk is investing $73m in the expansion of its manufacturing facility in Clayton, North Carolina, to make room for increased production capacity for the biopharma giant’s insulin delivery services.
China leads the field in 'potential future' API suppliers, positioning it to become a dominant force as these companies develop, Thomson Reuters said at CPhI 2010.
GlaxoSmithKline has told its workforce that 55 jobs will be axed at its manufacturing base in Currabinny, Co Cork, and 66 jobs will be lost as a result of revised shift-working plans.
Mark Weinstein, CEO of Bioclinica, has hit back at a public letter from Nicusa Capital CEO, Paul Johnson, claiming that the company's corporate strategy is 'flawed' and demanding the resignation of three top executives.
Univar is now exclusively distributing Dow's Carbowax Sentry PEGs in Europe and the range is proving popular at CPhI 2010 with manufacturers facing restricted supply from other sources.
Galapagos’ acquisition, Argenta, has signed up to a $46m cancer drug discovery service deal with Janssen Pharmaceutica, aimed at delivering novel cancer drug candidates.
Parexel opens its third office in Japan to address rising demands for clinical development and regulation services, and to supplement the capabilities of its Tokyo office which opened in 1997.
Belgium-based biopharmaceutical company, ThromboGenics, has signed a ten-year supply agreement with MSD Biologics, to produce microplasmin for the treatment of retinal disorders.
Gilead Sciences has received a warning letter from the US Food and Drug Administration (FDA) concerning manufacturing problems at the San Dimas, California, plant, where HIV medicines are made.
Precos is aiming to accelerate growth of its attrition-reducing preclinical oncology screening services by naming a co-founder of ClinPhone as chairman.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Oso BioPharmaceuticals, Creabilis SA and Clondalkin.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at Kendle, INC, AAIPharma and ClinTec.
BioClinica shareholder Nicusa Capital is calling for the resignation of CEO Mark Weinstein, CFO Ted Kaminer and Chairman David Nowiki, after describing the firm’s corporate strategy as “defective.”
Quintiles has established a joint venture with Health Kare Pharma International (HKPI) and Ramco Import and Export, focused on providing pharmaceutical contract sales and promotional services in Egypt.
Adoption of electronic submission by regulators around the world is good news for drugmakers’ efforts to access emerging markets says industry expert Kate Wilber.
High production volumes, a reduction in the total cost of ownership, flexibility and a speedy delivery time are benefits claimed by Bosch for its new range of infeed systems launched this week at FachPack in Germany.
Covance has added a 40,000 sq ft biotech laboratory to its site in Indiana, US site to support its relationship with Eli Lilly and boost capacity outside Europe.
Anglo-German company Evotec is joining forces with Almirall to identify small molecule modulators of an ion channel target involved in respiratory diseases.
The US FDA and NIH are funding research into bioinformatics-modelling of nanoparticles as part of a collaborative initiative to advance regulatory science.
Xcelience is shortening scale-up time from development to GMP production of clinical trial materials through the installation of dry granulation technology.
From 2005 to 2009 61 per cent of US NIH registered trials included at least one study site outside North America. Outsourcing-Pharma presents this, the 2009 downturn in US trials and other data as an interactive visualisation.
RTS Life Science has formed a Pharmaceutical Testing Group to integrate UK developed products for inhaler and tablet testing with US developed products for dissolution and content uniformity testing.
Porsolt seeks to broaden its services and client base with a new US AAALAC accredited preclinical contract research facility providing non-GLP and GLP specialist pharmacology services to the global pharmaceutical and biotech industry.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.
Advanced cardiovascular and metabolic services will be provided to biopharm by a strategic collaboration between CROs Cardialysis and Sticares InterACT.
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing sector, including appointments at INC Research, Velesco, Acurian, Asterand and Cmed.
The world’s biggest drugmaker, Pfizer, is set to bulk up its collaborative research partnerships with CROs and academics in Asia to lower costs and produce more affordable drugs.
